Location History:
- West Lafayette, IN (US) (1999 - 2000)
- San Diego, CA (US) (2005 - 2007)
Company Filing History:
Years Active: 1999-2007
Title: John Emil Johnson: Innovator in Plant Virus Technology
Introduction
John Emil Johnson is a notable inventor based in San Diego, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of modified plant viruses. With a total of 4 patents, his work has implications for vaccine development and other biological applications.
Latest Patents
One of his latest patents is titled "Modified plant viruses as vectors." This invention relates to assembled particles of a plant virus that contain a predetermined foreign peptide as part of the coat protein of the virus. The foreign peptide is preferably a biologically functional peptide, which enhances its biological application when presented in association with a larger molecule or particle. Another significant patent is "Modified plant viruses as vectors of heterologous peptides." This invention also involves assembled particles of a plant virus containing a foreign peptide insert in the coat protein. The site of the insert is designed to be free from direct sequence repeats flanking the insert, and the invention includes a method for producing these particles and their use, particularly in vaccines.
Career Highlights
Throughout his career, John Emil Johnson has worked with various organizations, including Axis Genetics Plc and Purdue Research Foundation. His innovative work has positioned him as a key figure in the biotechnology sector, particularly in the development of plant virus technologies.
Collaborations
John has collaborated with notable individuals in his field, including George Peter Lomonossoff and Mary M Bendig. These collaborations have further enriched his research and contributions to biotechnology.
Conclusion
John Emil Johnson's work in modified plant viruses showcases his innovative spirit and dedication to advancing biotechnology. His patents reflect a commitment to developing new methods that could significantly impact vaccine technology and biological applications.